Differential effects of adulterated versus unadulterated forms of linoleic acid on cardiovascular health

According to the classic ＂diet-heart＂ hypothesis, high dietary intake of saturated fats and cholesterol combined with low intake of polyunsaturated fats can increase levels of serum cholesterol and lead to the development of atherogenic plaques and ultimately cardio- vascular diseases. Recently, the beneficial health effects of omega-6 polyunsaturated fatty acids, particularly linoleic acid （LA）, on cardiovascular health have been called into question with some scientists suggesting that consumption of LA should be reduced in Western countries. The focus of this critical review is on the controversy surrounding the effects of dietary intake of LA on cardiovascular health. Specifically, we critically examined the effects of both unadulterated and adulterated forms of LA on cardiovascular health outcomes based on findings from epidemiological studies and randomized controlled trials. Additionally, we address common concems surrounding dietary intake of LA regarding its relationship with arachidonic acid, the ratio of omega-6 to omega-3 fatty acids, and its relationship with inflammation. Our critical review indicates that unadulterated forms of LA are cardioprotective and should be consumed as part of a healthy diet. In contrast, abundant evidence now indicates that adulterated forms of LA, predominantly hydrogenated vegetable oils, are atherogenic and should not be considered part of a healthy diet. The ability to adulterate the natural omega-6 fatty acid, LA, has contributed to mixed findings regarding the effects of this fatty acid on cardiovascular health. Thus, it is critical that the source of LA be taken into account when drawing conclusions about the physiological effects of this fatty acid. The findings of the present review are in line with current dietary recommendations of the American Heart Association.

Effect of a novel dietary supplement on pH levels of healthy volunteers:a pilot study

OBJECTIVE： To examine the effects of a greens alkalizing dietary supplement on urinary pH levels in individuals with lower-than-average pH levels. METHODS： The present study investigated the effects of an alkalizing formula （Reserveage Wholeganic GreensTM） on four individuals who had average urinary pH levels below 6.0 for three consecutive days. Following the three-day, baseline period, participants received Reserveage Wholeganic GreensTM for four consecutive days and were instructed to continue to measure their urine pH levels. Paired samples t-tests were used to examine pH levels before and after a four-day treatment period with Reserveage Wholeganic GreensTM. RESULTS： Compared to baseline, mean urine pH levels in all volunteers were significantly higher following the supplementation with Reserveage Wholeganic GreensTM （5.89 ±0.20 vs 5.56 ± 0.23; P〈0.01）. Participants＇ pH levels were also significantly higher than baseline on days 5, 6, and 7 of the treatment period （P 〈 0.05）. Noteworthy, on day 7, participants＇ mean pH levels were significantly higher than at the beginning of the treatment period （6.03 ± 0.15 at day 7 vs 5.65 ± 0.24 at day 4; P 〈 0.01）. CONCLUSION： The findings of this study suggest that supplementation with Reserveage Wholeganic GreensTM has an alkalizing effect on the body and can increase the urine pH levels in individuals with lower-than-average pH levels.

A systematic review of randomized controlled trials examining the effectiveness of saffron(Crocus sativus L.) on psychological and behavioral outcomes

BACKGROUND：Throughout the past three decades,increased scientifi c attention has been given to examining saffron’s（Crocus sativus L.）use as a potential therapeutic or preventive agent for a number of health conditions,including cancer,cardiovascular disease,and depression.OBJECTIVE：The purpose of this systematic review is to examine and categorize the current state of scientifi c evidence from randomized controlled trials（RCTs）regarding the effi cacy of saffron on psychological/behavioral outcomes.SEARCH STRATEGY：Electronic and non-electronic systematic searches were conducted to identify all relevant human clinical research on saffron.The search strategy was extensive and was designed according to the＂Preferred Reporting Items for Systematic Reviews and Meta-Analyses（PRISMA）.＂Reference lists of articles that met the inclusion criteria were searched.Only English language studies were reviewed.INCLUSION CRITERIA：Saffron trials in combination with other substances and saffron safety studies were considered,in accordance with the PRISMA statement.Included studies must have a control group.Included studies must measure a physiological and/or a behavioral outcome.DATA EXTRACTION AND ANALYSIS：The methodological quality of all included studies was independently evaluated by two reviewers using the Jadad score.Mean scores and P-values of measures were compared both inter-and intra-study for each parameter（i.e.,depression）.RESULTS：Twelve studies met our inclusion criteria.These studies examined the effects of saffron on psychological/behavioral outcomes of：major depressive disorder（n=6）,premenstrual syndrome（n=1）,sexual dysfunction and infertility（n=4）,and weight loss/snacking behaviors（n=1）.The data from these studies support the effi cacy of saffron as compared to placebo in improving the following conditions：depressive symptoms（compared to anti-depressants and placebo）,premenstrual symptoms,and sexual dysfunction.In addition,saffron use was also effective in reducing excessive snacking behavior.CONCLUSION：Findings from initial clinical trials suggest that saffron may improve the symptoms and the effects of depression,premenstrual syndrome,sexual dysfunction and infertility,and excessive snacking behaviors.Larger multi-site clinical trials are needed to extend these preliminary fi ndings.